A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018

Optimizing LDL-C Lowering With PCSK9 InhibitionПодробнее

Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'Подробнее

PCSK9 Antibody Dramatically Lowers LDLПодробнее

Clinical Experience With PCSK9 InhibitorsПодробнее

PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular EventsПодробнее

PCSK9 antagonists: A real breakthrough for management of familial hypercholesterolaemia? ESC2016Подробнее

PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16Подробнее

Alirocumab – a PCSK9 inhibitor for high cholesterolПодробнее

How your genes impact your LDL cholesterol: PCSK9 GeneПодробнее

Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor EvolocumabПодробнее

Cardiac_CPR2 LECT _PCSK9 Inhibitors (Staudinger)Подробнее

Case 2: Optimizing Cardiovascular Risk Reduction in High-Risk Patients Through Lipid ManagementПодробнее

New era in cholesterol-lowering? PCSK9 inhibitors soon available?Подробнее

PCSK9 inhibitors - Video abstract ID 83719Подробнее

PCSK9 Inhibitors for Cholesterol LoweringПодробнее

A crash course in cholesterol: PCSK9 inhibitorsПодробнее

Oral PCSK9 to drop LDL levels lowПодробнее

The Benefits of Early and Aggressive Lowering of LDL CholesterolПодробнее

What are the current unmet needs? | Professor Erik StroesПодробнее